毕马威：2025年全球生命科学行业首席执行官（CEO）展望报告（英文版）

In an age of heightened disruption, Life Sciences CEOs are optimistic. Many anticipate strong growth over the coming years on the back of new innovation and technology-driven increases in efficiency. Appetite for M&A remains high — particularly for new therapeutic areas and capabilities — while, at the same time, significant investment is being channeled towards operationalizing AI and other digitalization activities. This balance between innovation and efficiency is creating inte